Targeted and Improved Alzheimer''s Disease Drug Development

Project facts

Project promoter:
University Hospital Hradec Králové(CZ)
Project Number:
CZ-RESEARCH-0023
Status:
In implementation
Initial project cost:
€1,378,706
Donor Project Partners:
University of Oslo(NO)
Other Project Partners
Bioinova
a.s.(CZ)
Institute of Experimental Medicine CAS(CZ)
Programme:

Description

Through the international cooperation between the Czech Republic and Norway in applied research the project will create conditions for strengthening the development of knowledge based on the research results in biomedicine. The aim of the project is the development of compounds for the treatment of Alzheimer´s disease (AD). The project will include an approaches of personalized medicine during the development process in the way that novel compounds will be tested in a disease in a dish (DiD) model derived from AD patients.

Information on the projects funded by the EEA and Norway Grants is provided by the Programme and Fund Operators in the Beneficiary States, who are responsible for the completeness and accuracy of this information.